Sintx Technologies, Inc., an advanced ceramics and biomaterials company, engages in the research, development, manufacturing, and commercialization of silicon nitride biomaterials, composites, devices, and related technologies for medical and other applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). It also provides insulators for Tier 1 aerospace suppliers; SiNAPTIC® Foot & Ankle Osteotomy Wedge System for reconstructive surgery; OEM manufacturing of spinal implants; and SiNERGY technology platform for bio composite and 3D printing applications. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.…
SINTX Strengthens Patent Portfolio to Support International Growth Across Healthcare Markets
Sintx Technologies (NASDAQ: SINT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 32 employees.
The shares were at 1.100 USD on 20 November 2026, down 67.6% over 52 weeks. Its 52-week range is 1.090 USD to 4.460 USD, and it trades at the bottom of that range.
Its market capitalisation is 8.31M USD.
Sintx Technologies reports return on equity of -353.8%, an operating margin of -298.9% and revenue up 952.9% year over year.
Its debt exceeds its cash by 999.00K USD, a debt-to-equity ratio of 1.11. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.